Home Tags OneVentures
Cloud-powered people management platform Employment Hero yesterday announced it had secured AU$22 million in Series C funding, in a round led by...
Graduates of the 2017 program are now eligible to apply for an upcoming closed-door Shark Tank-style investor pitch event, where medtech VC’s and Angels with collective $1 billion funds under management will review investment opportunities
Employment Hero has announced it has extended its over-subscribed $3 million capital raise by 50 per cent, bringing the startup’s total funding to $4.5 million with additional investment from new and existing investors.
The Australian start-up scene has much to look forward to. Australian venture capital firm OneVentures has announced the first close on its Innovation and Growth...
OneVentures launches its second fund to tap into Australian investors’ growing appetite for venture...
Australian venture capital firm, OneVentures, recently officially launched its new OneVentures Innovation and Growth Fund II. This new fund aims to raise a total of...
The Best Day might just have lived up to its name – for angel investors and a venture firm backing the Sydney startup, as much as for founder Whitney Komor. Actually, make it The Best Days for Komor. She had not one but two best days on the trot when she wowed investors.
biNu, a four-year-old Sydney startup, is not the only one seeking to do so but might have just became the most high-profile one – what with a $2 million funding round led by former Google CEO Eric Schmidt’s TomorrowVentures, and including WorldReader founder David Risher and other private investors in Australia and the U.S.
Paloma Mobile Pty Ltd, founded less than a year ago to deliver rich apps and services optimised for low-cost smartphones in poorer global markets, has won a ringing endorsement of its busines with a $1.5 million Series A funding led by OneVentures.
The Nanopatch, a revolutionary new needle-free device for delivering vaccines, has won a $15 million capital injection (pun intended), but also was an award winner at World Vaccine Congress. After eight years of research, the Nanopatch looks set to revolutionise vaccination delivery forever.
On World Sight Day, judges of the University of Queensland (UQ) Business School’s $100,000 Enterprize competition finals voted resoundingly for an innovation that could control the world’s single largest cause of blindness – cataract, a clouding of the eye’s lens among older populations. Calpain Therapeutics, an Adelaide startup that has developed a drug that can slow the onset of cataract, won the nation’s richest business plan competition, ahead of four others shortlisted.
Vaxxas Pty. Ltd. has won a $15 million investment from venture groups led by OneVentures. Other investors include Brandon Capital Partners, the Medical Research Commercialisation Fund and U.S.-based HealthCare Ventures. Vaxxas is the first Queensland company to be funded under the Bio Capital Fund, which has swelled to nearly $250 million, established last year with the help of Health Care Ventures and Eli Lilly, among others. The investment was negotiated in the main by UniQuest Pty Limited, the University of Queensland’s main commercialisation company.